References
- Evoy KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017;77(4):403–426. doi:10.1007/s40265-017-0700-x.
- Schjerning O, Rosenzweig M, Pottegard A, et al. Abuse potential of pregabalin: a systematic review. CNS Drugs. 2016;30(1):9–25. doi:10.1007/s40263-015-0303-6.
- Zellner N, Eyer F, Zellner T. Alarming pregabalin abuse in Munich: prevalence, patterns of use and complications. Dtsch Med Wochenschr. 2017;142(19):e140–e147. doi:10.1055/s-0043-104228.
- Caviness JN. Treatment of myoclonus. Neurother. 2014;11(1):188–200. doi:10.1007/s13311-013-0216-3.
- Levy A, Chen R. Myoclonus: pathophysiology and treatment options. Curr Treat Options Neurol. 2016;18(5):447. doi:10.1007/s11940-016-0404-7.
- Janssen S, Bloem BR, van de Warrenburg BP. The clinical heterogeneity of drug-induced myoclonus: an illustrated review. J Neurol. 2017;264(8):1559–1566. doi:10.1007/s00415-016-8357-z.
- Knake S, Klein KM, Hattemer K, et al. Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. Epilepsy Behav. 2007;11(3):471–473. doi:10.1016/j.yebeh.2007.06.012.
- Hakkinen M, Vuori E, Kalso E, et al. Profiles of pregabalin and gabapentin abuse by postmortem toxicology. Forensic Sci Int. 2014;241:1–6. doi:10.1016/j.forsciint.2014.04.028.
- Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern? CNS Drugs. 2014;28(6):491–496. doi:10.1007/s40263-014-0164-4.
- Chiappini S, Schifano F. A decade of gabapentinoid misuse: an analysis of the European medicines agency’s “suspected adverse drug reactions” database. CNS Drugs. 2016;30(7):647–654. doi:10.1007/s40263-016-0359-y.
- Healy DG, Ingle GT, Brown P. Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure. Mov Disord. 2009;24(13):2028–2029. doi:10.1002/mds.22286.
- Hellwig S, Amtage F. Pregabalin-induced cortical negative myoclonus in a patient with neuropathic pain. Epilepsy Behav. 2008;13(2):418–420. doi:10.1016/j.yebeh.2008.04.006.
- Shimizu T, Yoshida T, Kitamura K, et al. Disturbance of consciousness and involuntary movements caused by pregabalin. BMJ Case Rep. 2012;2012; doi:10.1136/bcr-2012-007559.